Click here to download the programme


programme 171017 day 1

 programme 171017 day 2

 programme 171017 day 3

Programme may be subject to change without prior notification.


Keynote Speakers


Blight 1121


Andrew R. Blight, Ph.D. - Guttman Lecture

Dr. Blight received his Ph.D. from the University of Bristol (UK) in 1976 for research on spinal cord development and motor function in lower vertebrates.  In 1998 he became Vice President for Research and Development at Acorda Therapeutics.  He has been Chief Scientific Officer at Acorda since 2004, responsible for laboratory research and a series of clinical trials in SCI and multiple sclerosis, which led to a drug approval in MS in 2010.  He has also contributed to continuing efforts to develop better understanding of, and methodology for, the design of clinical trials and outcome measures in SCI. In this effort, he is co-chair, with John Steeves, of SCOPE (Spinal Cord Outcomes Endeavor). 


Nicky Cullum


Prof Dame Nicky Cullum, DBE, PhD - Plenary Speaker

Nicky Cullum undertook a pharmacology degree alongside an RGN at the University of Liverpool and subsequently a PhD in pharmacology also at Liverpool. She founded the world’s first Centre for Evidence Based Nursing at the University of York and co-founded the journal Evidence Based Nursing. She was a founding member of the Cochrane Collaboration and has been Coordinating Editor of Cochrane Wounds since 1995. Nicky has been a National Institute for Health Research Senior Investigator since 2008, is a Fellow of both the UK Academy of Medical Sciences and the American Academy of Nursing and was made a Dame in the 2013 Queen’s Birthday Honours for services to wound care and nursing research.  She also holds honorary positions at the University of Queensland and Griffith University (both in Australia) and at Central Manchester University Hospitals NHS Foundation Trust


 Stephen Muldoon


Stephen Muldoon - Plenary Speaker

Stephen qualified as a registered general nurse in 1990. After working as staff nurse and nurse manager for Livability in the UK, he was seconded to work as Nurse Educator/Advisor at the Centre of the Rehabilitation of the Paralysed (CRP) in Bangladesh in 1996. This was to be the start of his “international career” and 21 years later he remains active and committed to increasing opportunities and quality of life for people with SCI, with a particular focus on the development of specialised SCI healthcare, rehabilitation and community inclusion services.  


Thomas Kessler


Prof. Dr. med. Thomas M. Kessler - Plenary Speaker

Thomas studied medicine at the universities in Fribourg, Lausanne, and Bern and underwent further education as a surgeon in Sursee and Zofingen. Thomas specialized in Neuro-Urology at the University Hospital of Innsbruck under Prof. Dr. med. Helmut Madersbacher (2004) and at the National Hospital for Neurology and Neurosurgery, University College London, under Prof. Dr. med. Clare J. Fowler (2008). In 2010, he became the head of Neuro-Urology at Balgrist University Hospital. He is the author of more than 130 publications in peer-reviewed medical journals and books. Apart from his work at Balgrist University Hospital, Thomas is the chairman of the Swiss Continence Foundation, the vice-president of the International Neuro-Urology Society, the president of the Swiss Society for Sacral Neuromodulation, and a member of several international and national societies as well as a reviewer of several medical journals.


Stephen McMahon ISCOS 2016v2


Stephen B McMahon, FMedSci - Plenary Speaker
Stephen McMahon is Sherrington Professor of Physiology at King’s College London, and Director of the London Pain Consortium. He has published more than 290 original research articles, many highly rated (H-index 93) and is co-editor of the Textbook of Pain. His current research is focused on neuro-immune interactions, particularly the neurobiology of chemokines, and the genetics and epigenetics of pain. Professor McMahon directs the London Pain Consortium, a collection of leading researchers in London and Oxford working to better understand chronic pain mechanisms and improve treatments. He is also the academic lead on a EU-IMI consortium called Europain, a collaboration of scientists working in academia and industry.